Grade 2‐4 hyperbilirubinemia was frequently observed in liver cancers with 54.1% and 81.8% of grade 1‐2 and grade 3‐4 elevation of ALT/AST, respectively (Table 3). The gene discussed is GPT; the disease is Hyperbilirubinemia.